Glucocorticoids and glucocorticoid receptor translational isoforms

糖皮质激素和糖皮质激素受体翻译亚型

基本信息

  • 批准号:
    8890110
  • 负责人:
  • 金额:
    $ 19.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-07-15 至 2016-09-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Glucocorticoids are indispensable in the treatment of inflammation although they are not effective in treating neutrophilic inflammation in subsets of patients. Our long-term goal is to understand the mechanisms by which the glucocorticoid receptor (GR) mediates cell-specific functions, as this information may be useful in the development of anti-inflammatory treatments with improved efficacy/risk ratios. The goal of this proposal is to determine the role of GR translational isoforms in neutrophil survival and functions. We have recently discovered that the GR has eight translational isoforms that have profoundly different effects on gene expression and cell functions. We hypothesize that selective GR translational isoforms mediate neutrophil resistance to glucocorticoid-induced apoptosis. We propose to increase the efficacy of glucocorticoids in circumventing neutrophilic inflammation by altering GR isoforms. To test our hypotheses, we will examine lenti virus-transduced human CD34+ cell-derived neutrophils, mouse bone marrow-derived neutrophils, and neutrophils in a murine asthma model. Studies in Aim 1 will determine whether the GR-A isoform will increase the sensitivity of neutrophils to glucocorticoid induced-apoptosis. We have found that primary neutrophils have predominantly the GR-D isoforms. In multiple leukocytes, the GR-A, but not the GR-D, isoform is proapoptotic. Our preliminary data also show that retinoic acid (RA) switches the GR-D to the -A isoform in neutrophils. If GR-A expressing neutrophils are sensitive to glucocorticoids, glucocorticoids may be effective in inhibiting neutrophilic airway inflammation. Aim 2 will determine whether translation factors such as heterogenous nuclear ribonucleoprotein L (hnRNP-L) regulate the selective expression of GR isoforms and glucocorticoid sensitivity of neutrophils. We have identified hnRNP-L as a GR-D associated translation factor. Knockdown of hnRNP-L in promyelocytic HL-60 cells switched the GR-D to -A isoform. We will test whether knockdown of hnRNP-L in neutrophils alter neutrophil glucocorticoid responses in vitro and in vivo. These studies will improve our understanding of the role of GR translational isoforms in neutrophilc inflammation. The GR-A isoform is anticipated to increase the ability of glucocorticoids to induce neutrophil apoptosis and to inhibi components of neutrophilic inflammation.
描述(由申请人提供):糖皮质激素在炎症治疗中是不可或缺的,尽管它们不能有效治疗部分患者的中性粒细胞炎症。我们的长期目标是了解糖皮质激素受体(GR)介导细胞特异性功能的机制,因为这些信息可能有助于开发具有改善功效/风险比的抗炎治疗。该提案的目标是确定 GR 翻译异构体在中性粒细胞存活和功能中的作用。我们最近发现 GR 有八种翻译异构体,它们对基因表达和细胞功能具有截然不同的影响。我们假设选择性 GR 翻译异构体介导中性粒细胞对糖皮质激素诱导的细胞凋亡的抵抗。我们建议通过改变 GR 亚型来提高糖皮质激素在规避中性粒细胞炎症方面的功效。为了检验我们的假设,我们将检查慢病毒转导的人 CD34+ 细胞来源的中性粒细胞、小鼠骨髓来源的中性粒细胞和小鼠哮喘模型中的中性粒细胞。目标 1 的研究将确定 GR-A 亚型是否会增加中性粒细胞对糖皮质激素诱导的细胞凋亡的敏感性。我们发现初级中性粒细胞主要具有 GR-D 亚型。在多种白细胞中,GR-A 同种型(而非 GR-D)具有促凋亡作用。我们的初步数据还表明,视黄酸 (RA) 将中性粒细胞中的 GR-D 转变为 -A 亚型。如果表达 GR-A 的中性粒细胞对糖皮质激素敏感,则糖皮质激素可能有效抑制中性粒细胞气道炎症。目标 2 将确定异源核核糖核蛋白 L (hnRNP-L) 等翻译因子是否调节 GR 亚型的选择性表达和中性粒细胞的糖皮质激素敏感性。我们已经确定 hnRNP-L 是 GR-D 相关的翻译因子。早幼粒细胞 HL-60 细胞中 hnRNP-L 的敲低将 GR-D 转变为 -A 亚型。我们将测试中性粒细胞中 hnRNP-L 的敲低是否会改变中性粒细胞体外和体内糖皮质激素反应。这些研究将提高我们对 GR 翻译异构体在中性粒细胞炎症中作用的理解。 GR-A 亚型预计会增加糖皮质激素诱导中性粒细胞凋亡和抑制中性粒细胞炎症成分的能力。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Identification of Eight Different Isoforms of the Glucocorticoid Receptor in Guinea Pig Placenta: Relationship to Preterm Delivery, Sex and Betamethasone Exposure.
  • DOI:
    10.1371/journal.pone.0148226
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Saif Z;Dyson RM;Palliser HK;Wright IM;Lu N;Clifton VL
  • 通讯作者:
    Clifton VL
A hotspot in the glucocorticoid receptor DNA-binding domain susceptible to loss of function mutation.
糖皮质激素受体DNA结合结构域中的热点易受功能突变的损失。
  • DOI:
    10.1016/j.steroids.2015.01.022
  • 发表时间:
    2015-04
  • 期刊:
  • 影响因子:
    2.7
  • 作者:
    Banuelos J;Shin SC;Lu NZ
  • 通讯作者:
    Lu NZ
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NICK LU其他文献

NICK LU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NICK LU', 18)}}的其他基金

Glucocorticoid induced G-CSF in lung inflammation
糖皮质激素诱导 G-CSF 治疗肺部炎症
  • 批准号:
    9336499
  • 财政年份:
    2016
  • 资助金额:
    $ 19.31万
  • 项目类别:
Glucocorticoids and glucocorticoid receptor translational isoforms
糖皮质激素和糖皮质激素受体翻译亚型
  • 批准号:
    8773073
  • 财政年份:
    2014
  • 资助金额:
    $ 19.31万
  • 项目类别:
Glucocorticoid receptor translational isoforms in asthma
哮喘中的糖皮质激素受体翻译亚型
  • 批准号:
    8240049
  • 财政年份:
    2009
  • 资助金额:
    $ 19.31万
  • 项目类别:
Glucocorticoid receptor translational isoforms in asthma
哮喘中的糖皮质激素受体翻译亚型
  • 批准号:
    7838659
  • 财政年份:
    2009
  • 资助金额:
    $ 19.31万
  • 项目类别:
Glucocorticoid receptor translational isoforms in asthma
哮喘中的糖皮质激素受体翻译亚型
  • 批准号:
    7786958
  • 财政年份:
    2009
  • 资助金额:
    $ 19.31万
  • 项目类别:
Glucocorticoid receptor translational isoforms in asthma
哮喘中的糖皮质激素受体翻译亚型
  • 批准号:
    8477836
  • 财政年份:
    2009
  • 资助金额:
    $ 19.31万
  • 项目类别:
Glucocorticoid receptor translational isoforms in asthma
哮喘中的糖皮质激素受体翻译亚型
  • 批准号:
    7663499
  • 财政年份:
    2009
  • 资助金额:
    $ 19.31万
  • 项目类别:
Glucocorticoid receptor translational isoforms in asthma
哮喘中的糖皮质激素受体翻译亚型
  • 批准号:
    8448648
  • 财政年份:
    2009
  • 资助金额:
    $ 19.31万
  • 项目类别:
Glucocorticoid receptor translational isoforms in asthma
哮喘中的糖皮质激素受体翻译亚型
  • 批准号:
    8051828
  • 财政年份:
    2009
  • 资助金额:
    $ 19.31万
  • 项目类别:
Environment and Obesity: preventing stress hormone-induced obesity with genistein
环境与肥胖:用金雀异黄素预防应激激素引起的肥胖
  • 批准号:
    7090949
  • 财政年份:
    2007
  • 资助金额:
    $ 19.31万
  • 项目类别:

相似海外基金

Development of Enhanced Anti-inflammatory Blood Mononuclear Cell Therapy for ARDS and Elucidation of the Molecular Mechanism
ARDS增强抗炎血液单核细胞治疗的进展及分子机制的阐明
  • 批准号:
    23K07659
  • 财政年份:
    2023
  • 资助金额:
    $ 19.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Exploring therapeutic effects of anti-inflammatory and resolving factors in osteoporosis model mice
探讨抗炎和缓解因子对骨质疏松模型小鼠的治疗作用
  • 批准号:
    23K15705
  • 财政年份:
    2023
  • 资助金额:
    $ 19.31万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Investigation of the relation between age-related estradiol fluctuation and pro-/anti-inflammatory effects in transplant immune response.
研究年龄相关雌二醇波动与移植免疫反应中促/抗炎作用之间的关系。
  • 批准号:
    23K19490
  • 财政年份:
    2023
  • 资助金额:
    $ 19.31万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Non-coating anti-microbial, anti-host protein deposition, anti-inflammatory urinary catheter
无涂层抗菌、抗宿主蛋白沉积、抗炎导尿管
  • 批准号:
    10697567
  • 财政年份:
    2023
  • 资助金额:
    $ 19.31万
  • 项目类别:
Identification and optimization of verapamil as a novel neuroprotective and anti-inflammatory agent for reducing long-term neurological morbidities following organophosphate-induced status epilepticus
维拉帕米作为新型神经保护和抗炎剂的鉴定和优化,用于减少有机磷引起的癫痫持续状态后的长期神经系统发病率
  • 批准号:
    10727765
  • 财政年份:
    2023
  • 资助金额:
    $ 19.31万
  • 项目类别:
Anti-inflammatory Effects of Hydrogen Gas Produced by Gut Microflora in a Mouse Model of ARDS
肠道菌群产生的氢气对 ARDS 小鼠模型的抗炎作用
  • 批准号:
    23K08467
  • 财政年份:
    2023
  • 资助金额:
    $ 19.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Knockdown of AdipoR2 Compromises Adiponectin’s Anti-inflammatory Actions by Mainly Promoting a Pro-inflammatory Chemokine and Cytokine Secretory Profile in THP-1 Macrophages
AdipoR2 的敲低主要通过促进 THP-1 巨噬细胞中促炎趋化因子和细胞因子的分泌特征来损害脂联素的抗炎作用
  • 批准号:
    493138
  • 财政年份:
    2023
  • 资助金额:
    $ 19.31万
  • 项目类别:
Elucidation of anti-inflammatory mechanism of surface layer protein of lactic acid bacteria focusing on its interaction with lipopolysaccharide.
阐明乳酸菌表面层蛋白的抗炎机制,重点关注其与脂多糖的相互作用。
  • 批准号:
    23K13905
  • 财政年份:
    2023
  • 资助金额:
    $ 19.31万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
SBIR Phase I: Structure-guided design of anti-inflammatory modulators of protease-activated receptor 1 (PAR1)
SBIR I 期:蛋白酶激活受体 1 (PAR1) 抗炎调节剂的结构引导设计
  • 批准号:
    2223225
  • 财政年份:
    2023
  • 资助金额:
    $ 19.31万
  • 项目类别:
    Standard Grant
Targeting anti-viral and anti-inflammatory responses during ocular HSV-1 infection to prevent vision impairment.
针对眼部 HSV-1 感染期间的抗病毒和抗炎反应,以预防视力障碍。
  • 批准号:
    10651054
  • 财政年份:
    2023
  • 资助金额:
    $ 19.31万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了